Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Kinsella

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 22, 2012
Chronic adolescent exposure to delta-9-tetrahydrocannabinol in COMT mutant mice: impact on indices of dopaminergic, endocannabinoid and GABAergic pathwaysAine T Behan, Magdalena Hryniewiecka, Colm M P O'Tuathaigh, et al.
Schizophrenia Bulletin|June 10, 2005
Epidemiology of first-episode psychosis: illustrating the challenges across diagnostic boundaries through the Cavan-Monaghan study at 8 yearsPatrizia Baldwin, David Browne, Paul J Scully, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 20, 2009
Phenotype of spontaneous orofacial dyskinesia in neuregulin-1 'knockout' miceKatsunori Tomiyama, Colm M O'Tuathaigh, Gerard J O'Sullivan, et al.
Schizophrenia Research|August 16, 2015
Glasgow Antipsychotic Side-effects Scale for Clozapine - Development and validation of a clozapine-specific side-effects scaleCaroline Hynes, Dolores Keating, Stephen McWilliams, et al.
Schizophrenia Research|September 26, 2012
Prospective relationship of duration of untreated psychosis to psychopathology and functional outcome over 12 yearsMichele Hill, Niall Crumlish, Mary Clarke, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|October 20, 2007
Is the duration of untreated psychosis temporally stable?Deirdre Jackson, Richard Lawoyin, Keith Gaynor, et al.
The American Journal of Psychiatry|May 4, 2004
Obstetric adversity and age at first presentation with schizophrenia: evidence of a dose-response relationshipBrendan D Kelly, Larkin Feeney, Eadbhard O'Callaghan, et al.
Schizophrenia Research|November 10, 2009
Schizophrenia and the city: A review of literature and prospective study of psychosis and urbanicity in IrelandBrendan D Kelly, Eadbhard O'Callaghan, John L Waddington, et al.
Synapse (New York, N.Y.)|October 28, 2003
Comparative phenotypic resolution of spontaneous, D2-like and D1-like agonist-induced orofacial movement topographies in congenic mutants with dopamine D2 vs. D3 receptor "knockout"Katsunori Tomiyama, Fergal N McNamara, Jeremiah J Clifford, et al.
Neuropharmacology|March 28, 2008
Dopamine D1 vs D5 receptor-dependent induction of seizures in relation to DARPP-32, ERK1/2 and GluR1-AMPA signallingGerard J O'Sullivan, Mark Dunleavy, Kerstin Hakansson, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 22, 2012
Chronic adolescent exposure to delta-9-tetrahydrocannabinol in COMT mutant mice: impact on indices of dopaminergic, endocannabinoid and GABAergic pathwaysAine T Behan, Magdalena Hryniewiecka, Colm M P O'Tuathaigh, et al.
Schizophrenia Bulletin|June 10, 2005
Epidemiology of first-episode psychosis: illustrating the challenges across diagnostic boundaries through the Cavan-Monaghan study at 8 yearsPatrizia Baldwin, David Browne, Paul J Scully, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 20, 2009
Phenotype of spontaneous orofacial dyskinesia in neuregulin-1 'knockout' miceKatsunori Tomiyama, Colm M O'Tuathaigh, Gerard J O'Sullivan, et al.
Schizophrenia Research|August 16, 2015
Glasgow Antipsychotic Side-effects Scale for Clozapine - Development and validation of a clozapine-specific side-effects scaleCaroline Hynes, Dolores Keating, Stephen McWilliams, et al.
Schizophrenia Research|September 26, 2012
Prospective relationship of duration of untreated psychosis to psychopathology and functional outcome over 12 yearsMichele Hill, Niall Crumlish, Mary Clarke, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|October 20, 2007
Is the duration of untreated psychosis temporally stable?Deirdre Jackson, Richard Lawoyin, Keith Gaynor, et al.
The American Journal of Psychiatry|May 4, 2004
Obstetric adversity and age at first presentation with schizophrenia: evidence of a dose-response relationshipBrendan D Kelly, Larkin Feeney, Eadbhard O'Callaghan, et al.
Schizophrenia Research|November 10, 2009
Schizophrenia and the city: A review of literature and prospective study of psychosis and urbanicity in IrelandBrendan D Kelly, Eadbhard O'Callaghan, John L Waddington, et al.
Synapse (New York, N.Y.)|October 28, 2003
Comparative phenotypic resolution of spontaneous, D2-like and D1-like agonist-induced orofacial movement topographies in congenic mutants with dopamine D2 vs. D3 receptor "knockout"Katsunori Tomiyama, Fergal N McNamara, Jeremiah J Clifford, et al.
Neuropharmacology|March 28, 2008
Dopamine D1 vs D5 receptor-dependent induction of seizures in relation to DARPP-32, ERK1/2 and GluR1-AMPA signallingGerard J O'Sullivan, Mark Dunleavy, Kerstin Hakansson, et al.
Pageof 10